INSTI, two-drug regimen to demonstrate non-inferiority and a similar safety profile at Week 48 to BIC/FTC/TAF in adults living with HIV-1 who had not previously received antiretroviral ...

Our findings show that parathyroid hormone can reverse this process by activating natural signals that push these nerves away," says Dr. Crane. Parathyroid hormone (PTH) is produced by the parathyroid ...

Postmenopausal women taking tirzepatide and hormone therapy lost more body weight than those on tirzepatide alone. Hormone therapy users also had additional improvements in diastolic blood pressure, ...

Menopausal hormone replacement therapy (MHT) was once routinely used to relieve symptoms of menopause and protect against osteoporosis, heart disease, and possibly Alzheimer’s disease. It was thought ...

Share on Pinterest A combination of hormone therapy and the GLP-1 drug tirzepatide may promote weight loss in postmenopausal females. Image Credit: Mauro Grigollo/Stocksy A new study found that ...

Jeremy has more than 2300 published articles on Collider to his name, and has been writing for the site since February 2022. He's an omnivore when it comes to his movie-watching diet, so will gladly ...

BEERSE, Belgium, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has ...

Hormone therapy (HT) has proven effective for managing hot flashes and other common menopause symptoms, but questions remain about long-term safety, especially in women aged older than 65 years. A new ...

It's gonna be a big year for movies. After 2025 delivered the goods with a bunch of action movies well worth the price of admission, 2026 is locked and loaded with even bigger action-oriented popcorn ...

AMPLITUDE is the first clinical trial to evaluate potential therapies for patients with mHSPC and known HRR gene alterations, with positive results supporting the niraparib-based combination regimen ...

(MENAFN- GlobeNewsWire - Nasdaq) AMPLITUDE is the first clinical trial to evaluate potential therapies for patients with mHSPC and known HRR gene alterations, with positive results supporting the ...